Insider Transactions in Q4 2023 at Cyma Bay Therapeutics, Inc. (CBAY)
Insider Transaction List (Q4 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 18
2023
|
Charles Mc Wherter President of R&D |
SELL
Open market or private sale
|
Direct |
11,332
-27.3%
|
$237,972
$21.49 P/Share
|
Dec 18
2023
|
Charles Mc Wherter President of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
11,332
+21.4%
|
$56,660
$5.0 P/Share
|
Dec 15
2023
|
Paul T Quinlan General Counsel |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$105,000
$21.98 P/Share
|
Dec 15
2023
|
Paul T Quinlan General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$10,000
$2.94 P/Share
|
Dec 15
2023
|
Daniel Menold Vice President, Finance |
SELL
Open market or private sale
|
Direct |
21,497
-100.0%
|
$451,437
$21.99 P/Share
|
Dec 15
2023
|
Daniel Menold Vice President, Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
21,497
+50.0%
|
$128,982
$6.24 P/Share
|
Dec 11
2023
|
Janet Dorling |
SELL
Open market or private sale
|
Direct |
6,000
-100.0%
|
$120,000
$20.07 P/Share
|
Dec 11
2023
|
Janet Dorling |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+50.0%
|
$24,000
$4.63 P/Share
|
Dec 11
2023
|
Sujal Shah Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
64,865
-13.85%
|
$1,297,300
$20.4 P/Share
|
Dec 11
2023
|
Sujal Shah Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
64,865
+10.95%
|
$324,325
$5.0 P/Share
|
Nov 17
2023
|
Charles Mc Wherter President of R&D |
SELL
Open market or private sale
|
Direct |
11,342
-43.06%
|
$204,156
$18.28 P/Share
|
Nov 17
2023
|
Charles Mc Wherter President of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
11,342
+30.1%
|
$56,710
$5.0 P/Share
|
Nov 15
2023
|
Paul T Quinlan General Counsel |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$85,000
$17.38 P/Share
|
Nov 15
2023
|
Paul T Quinlan General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$10,000
$2.94 P/Share
|
Nov 15
2023
|
Daniel Menold Vice President, Finance |
SELL
Open market or private sale
|
Direct |
0
|
$0
$17.38 P/Share
|
Nov 15
2023
|
Daniel Menold Vice President, Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
17,500
+50.0%
|
$52,500
$3.45 P/Share
|
Nov 13
2023
|
Sujal Shah Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
64,863
-15.65%
|
$972,945
$15.89 P/Share
|
Nov 13
2023
|
Sujal Shah Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
64,863
+13.38%
|
$324,315
$5.0 P/Share
|
Nov 10
2023
|
Janet Dorling |
SELL
Open market or private sale
|
Direct |
7,000
-100.0%
|
$105,000
$15.24 P/Share
|
Nov 10
2023
|
Janet Dorling |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+50.0%
|
$28,000
$4.63 P/Share
|
Oct 18
2023
|
Charles Mc Wherter President of R&D |
SELL
Open market or private sale
|
Direct |
21,743
-59.18%
|
$304,402
$14.07 P/Share
|
Oct 18
2023
|
Charles Mc Wherter President of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
21,743
+37.18%
|
$108,715
$5.0 P/Share
|
Oct 16
2023
|
Paul T Quinlan General Counsel |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$65,000
$13.76 P/Share
|
Oct 16
2023
|
Paul T Quinlan General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$10,000
$2.94 P/Share
|
Oct 16
2023
|
Daniel Menold Vice President, Finance |
SELL
Open market or private sale
|
Direct |
0
|
$0
$13.76 P/Share
|
Oct 16
2023
|
Daniel Menold Vice President, Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
17,500
+50.0%
|
$52,500
$3.45 P/Share
|
Oct 09
2023
|
Sujal Shah Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
64,861
-27.46%
|
$908,054
$14.2 P/Share
|
Oct 09
2023
|
Sujal Shah Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
64,861
+21.55%
|
$324,305
$5.0 P/Share
|